Corrigendum to “High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients” [Translational Oncology 14 (2021) 101080]
Main Authors: | Chong Yuan, Kaili Chang, Chenyue Xu, Qingquan Li, Zunguo Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321001121 |
Similar Items
-
High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients
by: Chong Yuan, et al.
Published: (2021-07-01) -
Corrigendum: Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
by: Zeying Yu, et al.
Published: (2022-07-01) - Parit-parit [dll.]
-
Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma
by: Jinyu Xiang, et al.
Published: (2023-05-01) -
Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
by: Geffers, I, et al.
Published: (2007)